
Chicago Catholics pray for Pope Francis as he remains in critical condition
'I'm praying that he pulls through,' said Rose Williams, who attended morning Mass. 'He deserves that opportunity to continue to lead us, and so we just hope he'll pull through and be able to lead us through these trying times.'
The 88-year-old pope, who has a chronic lung disease and is prone to respiratory illnesses in winter, was admitted to Gemelli Hospital on Feb. 14 after a weeklong bout of bronchitis worsened. He suffered a prolonged asthmatic respiratory crisis while being treated for pneumonia and a complex lung infection, the Vatican said.
Blood tests show signs of early kidney failure but he remains alert and 'well-oriented,' according to the Vatican. He also participated in Mass with 'those who are caring for him during these days of hospitalization.'
Chicago Catholics praised the pope Sunday for his courage to speak out against injustice and his willingness to challenge traditional viewpoints in the Catholic Church.
'He's led by a lot of words, but his example is extraordinary,' said the Rev. Louis Cameli, a priest with the Archdiocese of Chicago and who has met Pope Francis.
Cameli pointed to the pope's 2013 visit to Lampedusa, an island in southern Italy, to meet with and pray for refugees and migrants as an example of that. The pope used his visit to the Island – a transit point for many African refugees – to spotlight the plight of migrants and asylum seekers fleeing war, persecution and poverty, a topic he has revisited often during his pontificate.
'He demonstrated with that visit that he is really concerned about people who are on the edge and that causes all of us, I think, to take another look at how we deal with people on the margins,' Carmeli said.
For some, the pope's more progressive actions were a welcome change. Ivan St. John, who lives in the Ukrainian Village and came to Holy Name to pray, liked how Pope Francis has been more welcoming to the LGBTQ+ population and has had more lenient stances on divorce compared to his predecessors.
'I think the Catholic Church needs to move forward with time,' St. John said. 'So I think he's been great in that sense, especially if you compare him to his predecessor, that he's been a really breath of fresh air.'
Theresa Armijo, who was visiting Chicago from New Mexico, expressed a similar sentiment.
'He really believes in the poor, and he's practiced it and he loves the Church and he loves its people,' Armijo said. She also expressed admiration for the pope's Argentinean origins.
'I love that he's from South America, because we have a lot of people…from South America that have not been represented because we've always had Italian popes, so I like that we shook it up a little bit,' Armijo said.
Others were not as enthusiastic with the pope's track record. Anna Leja, who stood outside Holy Name to raise awareness for the closed St. Adalbert's Catholic Church in Pilsen, wished the pope would have embraced a more traditional church.
'I think he was very confusing to a lot of Catholics,' Leja said, who said she was 'disgusted' by the pope's comments that people do not need to breed 'like rabbits ' in order to be good Catholics.
Despite these comments, Leja is still praying for the pope. 'He's old and he has all kinds of health problems, so at this point, I would pray for a good passing and that he is received in heaven' Leja said.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Digital Health In Neurology Market to Surpass Valuation of US$ 229.5 Billion By 2033
The market is rapidly advancing, driven by sophisticated software and empowered patients. This synergy is fostering a more personalized, accessible, and data-informed approach to managing complex neurological conditions worldwide. Chicago, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global digital health in neurology market was valued at US$ 38.9 billion in 2024 and is expected to reach US$ 229.5 billion by 2033, growing at a CAGR of 21.8% during the forecast period 2025–2033. Digital therapeutics (DTx) are emerging as a powerful new class of medicine. These software-based interventions deliver evidence-based therapeutic programs directly to patients. In the area of ADHD, Akili Interactive's EndeavorOTC is making significant inroads. A 2024 registry study revealed that 58.2% of its users reported having combined type ADHD. The data also highlighted significant comorbidities, with 69% of users reporting depression and 56% reporting an anxiety disorder. A remarkable 87% of users stated they had no to moderate symptom control with their existing ADHD treatments. For a quarter of users, difficulties in obtaining their medication prompted them to try EndeavorOTC in the digital health in neurology market. Download Sample Pages: Another innovation, the Revibe smartwatch for children with ADHD, demonstrated its efficacy in a study with 706 participants. Children using the device showed a more than 25-minute increase in attention span after just three weeks. The study also recorded a 19% increase in on-task behaviors. Further validation for EndeavorOTC came from a 2024 study of 220 adults, which found clear improvements in ADHD-related symptoms and overall quality of life. An earlier 2021 study of EndeavorRx for children with ADHD showed that after two months, over two-thirds of the 206 participants' parents reported improvements in their child's ADHD-related impairments. Key Findings in Digital Health in Neurology Market Market Forecast (2033) US$ 229.5 billion CAGR 21.8% Largest Region (2024) North America (39%) By End User Providers (43%) Top Drivers Increasing prevalence of neurological disorders globally. Advancements in AI and machine learning for diagnostics. Growing demand for remote patient monitoring solutions. Top Trends Integration of digital biomarkers in clinical trials. Rise of personalized digital therapeutics (DTx). Focus on consumer-centric neurological wellness applications. Top Challenges Data privacy and security concerns with sensitive health information. Ensuring equitable access to digital health technologies. Navigating complex regulatory and reimbursement landscapes. Virtual Care Platforms are Erasing Distances in Neurological Patient Management Telemedicine is dismantling traditional barriers to neurological care with remarkable speed in the digital health in neurology market. Virtual consultations and remote patient monitoring (RPM) are now standard practice, offering convenience and enhanced oversight. A 2024 survey of pediatric epilepsy providers found 67.9% of their centers now use video visits exclusively for telehealth. A vast majority, 83%, believe these platforms provide more equitable healthcare access. The removal of transportation barriers stands out as a significant driver for teleneurology adoption in 2024. Projections show that by 2025, over 71 million Americans will use some form of RPM service. The utility of telehealth is undeniable. The 2024 study also showed that 92.5% of pediatric epilepsy providers use it for reviewing test results, while 96.2% use it to discuss treatment plan changes. The financial and clinical impact is staggering. The telestroke services market is projected to reach USD 1.99 billion by 2025, with cloud-based platforms dominating 85.3% of that market. A lifetime analysis of a telestroke program revealed an average societal cost saving of $1,526 per patient. Patients also experienced an incremental gain of 0.45 quality-adjusted life years (QALYs). A separate hub-and-spoke telestroke network model demonstrated a lifetime cost saving of $1,436 per patient and a 0.02 QALY gain. A 5-year model of one such network projected an annual cost saving of $358,435 for the entire system, with each spoke hospital saving an estimated $109,080 annually. Ultimately, implementing a telestroke program was associated with a reduction of 101 nursing home residents per 10,000 patients. The digital health in neurology market is clearly benefiting from these efficiency gains. Wearable Technology Unleashes a Continuous Stream of Actionable Patient Data Wearable sensors and mobile health applications are fundamentally changing patient monitoring. They provide a continuous flow of real-world data, empowering both patients and clinicians. The digital health in neurology market is leveraging these tools for proactive disease management. In Parkinson's disease, Rune Labs' StrivePD platform saw its user network expand by 56% in 2024. A nine-month pilot study of the platform involving 138 patients yielded impressive results. Participants experienced a 42% reduction in emergency room visits and an 18% reduction in time needed with movement disorder specialists. The behavioral impact was also significant, with 90% of users increasing their exercise levels and 80% showing improved medication adherence. Rune Labs' 2024 research is powered by a rich dataset from over 1,000 Parkinson's patients using the platform. The momentum extends to other conditions as well. As of 2025, the global market for epilepsy monitoring devices is projected to be valued at an impressive USD 582.3 million. Artificial Intelligence Is Driving a New Era of Diagnostic Precision Artificial intelligence (AI) is supercharging diagnostic capabilities within digital health in neurology market. Machine learning algorithms can analyze complex medical data with unprecedented speed and accuracy. For Parkinson's disease, a condition where early diagnosis is challenging, a new AI software called Automated Imaging Differentiation for Parkinsonism (AIDP) has demonstrated the ability to increase diagnostic precision to beyond 96%. This is a monumental leap compared to the current diagnostic accuracy of 55% to 78% within the first five years. A systematic review of 127 studies on AI-driven Parkinson's diagnosis found accuracy rates consistently ranging from 78% to 96%. An experimental multimodal AI diagnostic framework achieved a 94.2% accuracy in detecting early-stage disease. A deep-learning model analyzing medical and prescription data from 820 Parkinson's patients achieved a diagnostic accuracy of 0.937 when using data from three years preceding diagnosis. When analyzing an even earlier period (3-6 years before diagnosis), the model's accuracy improved to 0.922 with the inclusion of medication data. The trend extends to other conditions, with the US FDA clearing the NeuroQuant 5.0 software, an AI-powered tool for assessing MRI scans of patients being treated for Alzheimer's disease. These advancements are a cornerstone of the digital health in neurology market. Immersive Virtual Reality Therapies Are Redefining Neurorehabilitation Possibilities Virtual Reality (VR) is creating highly engaging and effective therapeutic environments for neurological recovery. The technology is proving particularly useful for patients recovering from stroke, brain injuries, and amputations. In a groundbreaking clinical trial for phantom limb pain, a VR treatment requiring leg movements led to a 39.6% pain reduction among seven participants with lower-limb amputations. Even a distractor VR treatment without leg movements in the same study resulted in a notable 28% decrease in pain. This early success has prompted an expansion of the proof-of-concept study, which initially involved eight subjects with below-knee amputations, to a larger sample size. These immersive solutions represent a high-growth segment within the broader digital health in neurology market, offering new hope for patients undergoing difficult rehabilitation journeys. Digital Biomarkers Are Accelerating the Pace of Neurological Clinical Research Digital biomarkers are revolutionizing how researchers track disease progression and treatment efficacy. Collected via sensors and mobile devices, these objective data points provide a high-frequency view of a patient's condition. Their impact on clinical trial efficiency is profound in the digital health in neurology market. A trial simulation for a hypothetical Parkinson's digital biomarker showed it could lead to a 55.7% reduction in the number of subjects needed for a one-year trial if it detected disease progression just 1.5 times faster than standard assessments. The same simulation indicated that a digital biomarker with a 0.5-fold reduced standard deviation could allow for a trial with 70.0% fewer subjects per arm. Companies are actively building a presence in this space. As of 2024, Rune Labs, a key player focused on digital biomarkers for Parkinson's, had already participated in 15 scientific conferences to share its findings. Robust Investment and a Dynamic Competitive Landscape Signal Strong Market Confidence The financial community is taking notice of the immense potential in neurotechnology. Venture capital and strategic investments are flowing into the digital health in neurology market, fueling innovation. In 2024, European tech companies raised over €1.1 billion in seed funding, with total funding for startups reaching $51 billion. Healthcare and biotechnology was the leading investment sector, attracting over $11 billion. The median pre-seed funding round in Europe grew by 15.7% in the second half of 2024 to €870,000. Specific deals highlight this trend. In October 2024, iGent AI secured a €7.6M seed round, Nomos raised a €1.9M pre-seed round, and In Parallel secured €2.78 million. The competitive landscape is equally dynamic. Blackrock Neurotech received a massive $200 million investment from Tether in 2024, valuing the company at approximately $350 million. Its NeuroPort Array system, priced at over half a million dollars, has been sold to several dozen hospitals. Blackrock Neurotech's estimated annual revenue is $60.7 million, with an estimated revenue per employee of $306,778. Before the latest investment, the company had already raised $50 million and had seen early revenue grow from approximately $700,000 to $3.5 million. Meanwhile, Rune Labs announced a strategic $12 million investment round in 2024, bringing its total funding to $42 million. Its StrivePD platform is also being used in a care management program with Kaiser Permanente. Customize the Data Scope to Match Your Objectives: Evolving Regulations and Emerging Technologies Are Charting the Industry's Future The future of the digital health in neurology market is being shaped by evolving regulatory frameworks and next-generation technologies. Regulators are adapting to the unique nature of software-based medical devices. As of September 2023, Japan had approved only three therapeutic apps. To accelerate innovation, Japan's PMDA set a six-month target review time for priority Software as a Medical Device (SaMD) products as of January 2024. A new two-stage approval system for SaMD was also expected in 2024. Patient engagement is another critical factor. A Mayo Clinic study of its RPM program found a patient engagement rate over 78%. A latest report published in 2025 found that 62% of healthcare leaders in the digital health in neurology market believe Generative AI holds the highest potential for improving patient engagement. Indeed, a 2025 survey revealed 51% of people have already used Generative AI to help diagnose symptoms. Looking ahead, Brain-Computer Interfaces (BCIs) represent the next frontier. The global BCI market was valued at USD 2.3 billion in 2024 and is expected to soar to USD 4.5 billion by 2029. Pioneers like Blackrock Neurotech, with over 40 patients already implanted with their Digital Health In Neurology Market Key Players: AdvancedMD, Inc. Akili, Inc. AppliedVR, Inc. BigHealth Blackrock Neurotech. Cognivive, Inc. Neofect Co, Ltd Omada Health Inc. Proteus Digital Health, Inc. Teladoc Health, Inc. Other Prominent Players Key Market Segmentation: By Component Software Hardware Services By End-use Patients Providers Payers Others By Region North America Europe Asia Pacific Middle East & Africa South America Need a Detailed Walkthrough of the Report? Request a Live Session: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in to access your portfolio


Axios
6 hours ago
- Axios
RTP startup uses AI to fight health insurance denials
A Research Triangle Park startup wants to make appealing health insurance denials easier through a new artificial intelligence tool. Why it matters: A growing number of startups are turning to new AI tools to help patients navigate complex policies and byzantine processes to appeal insurance denials, according to NBC News. The number of prescription drug claims denied by insurance grew by 25% between 2016 and 2023, according to the New York Times. And in 2023, Affordable Care Act insurers denied 20% of claims, Axios reported. Driving the news: Enter Counterforce Health, a startup founded at the Frontier coworking campus in Research Triangle Park. The company's AI assistant drafts customized appeal letters that comb through a patient's policy, looking for the best line of defense, greatly reducing the amount of hours many patients spend drafting appeals. At the moment, few patients appeal denied claims at all, according to an analysis by KFF. Zoom in: Neal Shah, a former hedge fund manager turned startup founder, has been trying to change the health care industry he has found frustrating for years, through a succession of startups run by a handful of employees in RTP. Shah, who left his job on Wall Street to move back to North Carolina to take care of sick family members, is the founder of CareYaya, an online platform that helps connect people looking for at-home care workers with students studying health care. That platform has taken off in the past three years, growing from hundreds of workers based at Triangle-area universities to thousands across the country. Now, he's focused on expanding Counterforce Health, which he co-founded last year to provide free AI tools to patients and funding through several grant awards. The company's platform uses a variety of AI models to run its appeals process, pinging medical journals and insurance review commission data to make a case for why a patient's appeal should be granted. He views it as a way to counteract the algorithms that insurance companies use to deny claims. (Some insurance companies are currently being sued for using algorithms to deny claims, Axios previously reported.) What they're saying: "You end up spending hours and hours researching, fighting on the phone and just stressing the hell out," Shah told Axios about the current appeals process. "And many people will be too intimidated and scared to do that." In some ways, it's become a battle of AI versus AI in the insurance world, Shah added, and if the patient doesn't have a tool, "you lose." What's next: Right now, the Counterforce tools are free for patients and clinics to use. Some clinics are using the service, like Wilmington Health, to make it easier to draft appeals for its patients, and some pharmaceutical companies have begun reaching out to the team about the tools.


Time Magazine
6 hours ago
- Time Magazine
How Peace in the DRC Can Prevent the Next Global Epidemic
Peace is more than the end of conflict. Peace is the foundation for health security. Since January, thousands were killed and hundreds of thousands were displaced in eastern Democratic Republic of the Congo (DRC) in the fighting between M23 rebels and the Congolese army. Crucially, the war in eastern DRC also crippled the efforts to stem the spread of lethal diseases in a region already suffering from outbreaks of mpox, Ebola, cholera, malaria, and measles. In 2023, as the world was recovering from COVID-19 pandemic, more than 12,000 suspected cases of mpox, a viral disease closely related to smallpox, were reported in the DRC. The outbreak of war in January exacerbated the epidemics in eastern DRC as fighting wrecked the healthcare infrastructure and severely limited access to health services, especially the vaccinations. Most of the mpox cases in the DRC emerged in regions affected by armed conflict and turned these communities into epicenters of unchecked disease transmission. I lead the Africa Centres for Disease Control and Prevention, a public health agency of the African Union. Along with the World Health Organization and our other partners, we mobilized response teams and intervened with disease surveillance, vaccination, case management, and risk communication to stem the spread of mpox. The armed conflict in eastern DRC severely hampered our efforts to contain the outbreak. Disease surveillance teams had to grounded after travel became too dangerous. Clinics were looted. Health workers were attacked. Cold-chain vaccines never reached their destinations. For the communities living in regions affected by the conflict, the promise of vaccination remained a mirage. Read More: It Has Never Been Harder to Be a Humanitarian The mpox outbreak spread beyond the DRC's borders by July and affected lives and livelihoods in more than 25 African countries. In 2024, 72,506 cases of mpox and 1,288 deaths were reported by 20 African Union countries. By late July, 89,566 mpox cases were reported by 25 African Union countries, and 720 deaths were reported by eight member states. On July 19, the DRC government and M23 rebels signed a Declaration of Principles in Qatar, committing to a peace agreement, which offers the opportunity to rebuild health systems, restore early warning mechanisms, and reach vulnerable communities with lifesaving care. Without peace, diseases spread unchecked. With peace, outbreaks can be contained at their source. What happens in eastern DRC could determine whether the next pandemic is prevented or allowed to spread globally. Waging peace, preventing epidemics Health security cannot be achieved without peace. We welcome the DRC peace agreement signatories have committed to increasing cross-border public health cooperation, including joint disease prevention in border areas, coordinating epidemic outbreak control, and sharing information to advance scientific research and health-related commercial opportunities. Peace enables the vaccination of vulnerable children, testing and treatment of diseases like malaria and mpox, and restoration of early warning systems that have long been underperforming. Peace helps rebuild trust, which helps people decide whether to seek care, accept vaccines, or report symptoms. Without it, even the best interventions fail. And peace means mobile clinics can finally reach forgotten communities. Peace creates the conditions to rebuild and transform the DRC's health system into a resilient, inclusive, and community-centered system that can withstand future shocks and serve generations to come. To achieve all this, we need urgent investments in peace, health infrastructure, and equitable access to care. We at the Africa CDC proposed a regional health investment plan to the United States positioning health as a core driver of economic growth, peacebuilding, and regional integration, a plan that would bring together the DRC, Rwanda, Angola, and Zambia. Our proposal, aligned with the U.S.–Africa health security partnerships, seeks $645 million to finance health systems in and around mining corridors—disease surveillance labs, emergency responses, worker and community health services—to reduce risks of future epidemics shutting down mines and critical mineral supply chains. The funding for this health finance initiative would serve as a springboard to raise $3 billion in co-financing from development banks, private sectors and philanthropic organizations for health-related mining infrastructure. Our proposal presents a model for connecting biosecurity with economic resilience by integrating health infrastructure into vital mineral corridors, deploying advanced bio-surveillance technologies, and creating up to 100,000 jobs through local manufacturing. It would ensure that mineral security is supported by strong health systems across Central and Southern Africa. Rebuilding Africa's health systems The government of the DRC must place health at the center of its recovery agenda. Along with rebuilding healthcare facilities, it requires investing in a skilled health workforce, strengthening disease surveillance systems, and ensuring communities have access to timely care. Outbreaks must be detected and contained early, before they spiral into crises. Cross-border coordination and disease surveillance are essential as viruses do not respect borders. An outbreak in a remote village can become a global emergency, as the mpox epidemic has shown. International donors and global health agencies must shift their approach from emergency aid to helping rebuild health systems. That means funding malaria prevention, mpox response, and resilient, community-based surveillance networks. Read More: Cutting mRNA Research Could Be Our Deadliest Mistake Yet And finally, the negotiating parties—the DRC, Rwanda and M23 rebels—must uphold humanitarian access and protect the right to health as a cornerstone of peace. A permanent ceasefire must be implemented and respected. When diseases are allowed to spread in silence and mistrust and misinformation fester, we risk the next global pandemic. When communities are empowered, when health systems are strong, when peace is more than a promise, it becomes a platform for health security and progress. The peace agreement in the DRC has the potential to shape the future for generations. The next outbreak can be stopped before it starts. A child with malaria can survive. And epidemics like mpox can be controlled at their origin. Peace is the beginning of healing, rebuilding, resilience. The United States and the world must not look away.